SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008314
Filing Date
2018-11-02
Accepted
2018-11-02 08:46:17
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20180930x10q.htm 10-Q 1187991
2 EX-31.1 glyc-20180930ex3117b137d.htm EX-31.1 18160
3 EX-31.2 glyc-20180930ex312db7edb.htm EX-31.2 17211
4 EX-32.1 glyc-20180930ex321ba450f.htm EX-32.1 10263
  Complete submission text file 0001558370-18-008314.txt   4444842

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20180930.xml EX-101.INS 901865
6 EX-101.SCH glyc-20180930.xsd EX-101.SCH 31116
7 EX-101.CAL glyc-20180930_cal.xml EX-101.CAL 29663
8 EX-101.DEF glyc-20180930_def.xml EX-101.DEF 124532
9 EX-101.LAB glyc-20180930_lab.xml EX-101.LAB 286909
10 EX-101.PRE glyc-20180930_pre.xml EX-101.PRE 228249
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 181155585
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1